LONG GROVE, Ill., Sept. 11, 2017 -- Forsight Vision wants to remind parents about the importance of adding eye exams to their back-to-school checklists by promoting their second annual campaign. For every comprehensive children’s eye exam completed in August, September, or October, they will make a donation to a non-profit organization.
As students get ready to head back to class, the team at Forsight Vision wants to remind parents of the importance of adding eye exams to their to-do lists.
“Good vision has been long proven crucial to a child’s success in school,” says Dr. Todd Cohan, O.D. “In fact, up to eighty percent of children’s learning comes from visual processing. To put it simply, kids can’t focus on learning if they can’t see the board or their textbooks clearly. And that’s why we started this campaign to help bring awareness.”
Comprehensive eye exams for children usually only take a short period of time, but can lead to diagnosing issues that may have been missed. In fact, some younger children may not be able to communicate well that they are having a problem seeing and an eye exam can help start the process of correction.
“As a parent myself, I know just how daunting the list of appointments and supplies can be at the start of the new school year. But parents really need to make a vision exam a priority,” continues Dr. Cohan.
In addition, parents also need to be aware that the screenings often provided at schools during the year aren’t always adequate enough.
“Screenings don’t check for all the same things,” Dr. Cohan explains. “Many parents rely on those screenings to be an indicator of vision problems for their kids, but the truth is that they could be missing important symptoms that create big issues in the classroom. By visiting our team, we can help diagnose and treat vision problems right away.”
Besides just helping children in the area, Forsight Vision wants to take things a step further. That’s why they are offering to make a donation to a non-profit for every comprehensive eye exam completed during August, September, and October for children ages 18 and under. The specific charities will be chosen by Forsight Vision staff and Facebook followers.
“We like to think of it as our way of helping our patients and giving back to the community,” explains Dr. Cohan. “It’s something we’re really proud to be able to do.”
Patients can schedule their appointments with the optometrists on staff, Dr. Todd Cohan and Dr. Emily Pott.
About Forsight Vision
Forsight Vision offers quality optometry care for patients of all ages in Long Grove, Illinois. Services range from routine comprehensive exams to contact lens fitting, disease treatment, vision loss prevention, and specialty optometric care. For more information or to schedule an appointment, please call (847) 955-9393.
Forsight Vision, Ltd. 4160 IL Route 83 Suite 107 Long Grove, IL 60047 (847) 955-9393


ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
FDA Approves Mitapivat for Anemia in Thalassemia Patients
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



